ICU Medical Statistics
Total Valuation
ICU Medical has a market cap or net worth of $2.90 billion. The enterprise value is $4.01 billion.
Important Dates
The next confirmed earnings date is Thursday, November 6, 2025, after market close.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ICU Medical has 24.69 million shares outstanding. The number of shares has increased by 1.33% in one year.
| Current Share Class | 24.69M |
| Shares Outstanding | 24.69M |
| Shares Change (YoY) | +1.33% |
| Shares Change (QoQ) | +0.69% |
| Owned by Insiders (%) | 1.23% |
| Owned by Institutions (%) | 102.46% |
| Float | 23.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.22 |
| Forward PS | 1.35 |
| PB Ratio | 1.37 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 48.00 |
| P/OCF Ratio | 20.92 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 12.10, with an EV/FCF ratio of 66.26.
| EV / Earnings | n/a |
| EV / Sales | 1.69 |
| EV / EBITDA | 12.10 |
| EV / EBIT | 32.45 |
| EV / FCF | 66.26 |
Financial Position
The company has a current ratio of 2.44, with a Debt / Equity ratio of 0.66.
| Current Ratio | 2.44 |
| Quick Ratio | 1.01 |
| Debt / Equity | 0.66 |
| Debt / EBITDA | 3.99 |
| Debt / FCF | 23.22 |
| Interest Coverage | 1.21 |
Financial Efficiency
Return on equity (ROE) is -1.78% and return on invested capital (ROIC) is 2.13%.
| Return on Equity (ROE) | -1.78% |
| Return on Assets (ROA) | 1.84% |
| Return on Invested Capital (ROIC) | 2.13% |
| Return on Capital Employed (ROCE) | 3.41% |
| Revenue Per Employee | $158,167 |
| Profits Per Employee | -$2,463 |
| Employee Count | 15,000 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 2.34 |
Taxes
In the past 12 months, ICU Medical has paid $52.85 million in taxes.
| Income Tax | 52.85M |
| Effective Tax Rate | 332.40% |
Stock Price Statistics
The stock price has decreased by -31.58% in the last 52 weeks. The beta is 0.83, so ICU Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | -31.58% |
| 50-Day Moving Average | 124.11 |
| 200-Day Moving Average | 136.27 |
| Relative Strength Index (RSI) | 47.71 |
| Average Volume (20 Days) | 217,681 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ICU Medical had revenue of $2.37 billion and -$36.95 million in losses. Loss per share was -$1.51.
| Revenue | 2.37B |
| Gross Profit | 850.28M |
| Operating Income | 123.56M |
| Pretax Income | 15.90M |
| Net Income | -36.95M |
| EBITDA | 331.34M |
| EBIT | 123.56M |
| Loss Per Share | -$1.51 |
Full Income StatementBalance Sheet
The company has $300.03 million in cash and $1.40 billion in debt, giving a net cash position of -$1.10 billion or -$44.76 per share.
| Cash & Cash Equivalents | 300.03M |
| Total Debt | 1.40B |
| Net Cash | -1.10B |
| Net Cash Per Share | -$44.76 |
| Equity (Book Value) | 2.12B |
| Book Value Per Share | 85.71 |
| Working Capital | 697.34M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $138.83 million and capital expenditures -$78.31 million, giving a free cash flow of $60.52 million.
| Operating Cash Flow | 138.83M |
| Capital Expenditures | -78.31M |
| Free Cash Flow | 60.52M |
| FCF Per Share | $2.45 |
Full Cash Flow StatementMargins
Gross margin is 35.84%, with operating and profit margins of 5.21% and -1.56%.
| Gross Margin | 35.84% |
| Operating Margin | 5.21% |
| Pretax Margin | 0.67% |
| Profit Margin | -1.56% |
| EBITDA Margin | 13.97% |
| EBIT Margin | 5.21% |
| FCF Margin | 2.55% |
Dividends & Yields
ICU Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.33% |
| Shareholder Yield | -1.33% |
| Earnings Yield | -1.27% |
| FCF Yield | 2.08% |
Dividend DetailsAnalyst Forecast
The average price target for ICU Medical is $179.40, which is 52.46% higher than the current price. The consensus rating is "Buy".
| Price Target | $179.40 |
| Price Target Difference | 52.46% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 1.83% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 18, 2002. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Mar 18, 2002 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
ICU Medical has an Altman Z-Score of 2.24 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.24 |
| Piotroski F-Score | 7 |
